Acorda slides on complete response for diazepam nasal spray

Acorda Therapeutics Inc. (NASDAQ:ACOR) was down $3.51 (10%) to $32.39 on Friday after FDA issued a complete response letter for Plumiaz diazepam nasal spray to treat acute repetitive seizures in epile...